Jason Buckner
Pediatric Endocrinology · Indianapolis, INNPI 1750675518
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,045, 9.1 times the $226 reported in 2019. That places this record below the midpoint for pediatric endocrinology clinicians in IN, where the typical reported total is $4,834.
Across 64 payments — averaging $75.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$741
- Ascendis Pharma Endocrinology Inc$605
- Abbott$457
- Mannkind Corporation$346
- Insulet Corporation$332
- Neurocrine Biosciences, Inc.$267
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,822100%
- Education$110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 11 | $741 |
| Ascendis Pharma Endocrinology Inc | 5 | $605 |
| Abbott | 3 | $457 |
| Mannkind Corporation | 3 | $346 |
| Insulet Corporation | 7 | $332 |
| Neurocrine Biosciences, Inc. | 2 | $267 |
| Soleno Therapeutics, Inc. | 3 | $249 |
| Sanofi-aventis U.S. LLC | 2 | $240 |
| Medtronic(2 entities) | 3 | $186 |
| Tolmar Pharmaceuticals, Inc. | 2 | $169 |
| BETA Bionics, Inc. | 4 | $163 |
| Eton Pharmaceuticals, Inc. | 1 | $150 |
| Sequel Med Tech, LLC | 2 | $139 |
| Pfizer | 2 | $138 |
| Endo USA, Inc. | 1 | $134 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Azurity Pharmaceuticals, Inc. | 1 | $116 |
| Dexcom, Inc. | 1 | $115 |
| AbbVie | 4 | $70 |
| Novo Nordisk | 3 | $57 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SKYTROFA$402
- t:slim X2 Insulin Pump with Control-IQ$357
- FreeStyle Libre 2$315
- iLet Bionic Pancreas$306
- AFREZZA$274
- CRENESSITY$267
- Omnipod$258
- TZIELD$240
- VYKAT XR$237
- Alkindi$150
- KHINDIVI$150
- INCRELEX$150
- MINIMED 780G$149
- FREESTYLE LIBRE 3$141
- SUPPRELIN$134
- FENSOLVI$125
- NGENLA$125
- GVOKE HYPOPEN$122
- TWIIST$120
- Triptodur$116
How this compares
$4,834 in reported general payments places this provider in the 50th percentile of 27 pediatric endocrinology providers in Indiana.
Other pediatric endocrinology in Indianapolis
- Gordon CutlerIndianapolis$305K
- Emily SimsIndianapolis$236K
- Linda di MeglioIndianapolis$96K
- Erik ImelIndianapolis$69K
- Jamie FeltonIndianapolis$34K
- Erica EugsterIndianapolis$21K
- John FuquaIndianapolis$20K
- Rebecca AguirreIndianapolis$13K
- Hebatullah IsmailIndianapolis$9K
- Eric ChangIndianapolis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.